RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Vincent Bond to Disease Progression

Back to Details
This is a "connection" page, showing publications Vincent Bond has written about Disease Progression.
Vincent Bond
Connection Strength
0.063
Disease Progression
  1. Aikhionbare FO, Newman C, Womack C, Roth WW, Stringer HG, Bond VC. Characterization of a third CCR5 amplicon from CCR5-delta32-heterozygous HIV-1-infected individuals. AIDS. 1999 Aug 20; 13(12):1585-6.
    View in: PubMed
    Score: 0.036
  2. Katkoori VR, Basson MD, Bond VC, Manne U, Bumpers HL. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers. Oncotarget. 2015 Sep 29; 6(29):27763-77.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support